Susquehanna International Group, LLP Pacira Bio Sciences, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

27 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$11.7 - $28.46 $386,100 - $939,180	33,000 Added 59.25%	88,700 $1.34 Million
Q2 2024 Aug 15, 2024	BUY	$25.5 - $31.51 $1.42 Million - $1.76 Million	55,700 New	55,700 $1.59 Million
Q4 2023 Feb 14, 2024	BUY	$26.32 - $34.31 $2.94 Million - $3.83 Million	111,600 Added 316.15%	146,900 $4.96 Million
Q3 2023 Nov 14, 2023	SELL	$30.68 - $40.09 $886,652 - $1.16 Million	-28,900 Reduced 45.02%	35,300 $1.08 Million
Q2 2023 Aug 11, 2023	BUY	$36.12 - $47.5 $104,747 - $137,750	2,900 Added 4.73%	64,200 $2.57 Million
Q1 2023 May 16, 2023	BUY	$35.53 - $43.38 $2.18 Million - $2.66 Million	61,300 New	61,300 $2.5 Million
Q3 2022 Nov 14, 2022	BUY	$51.24 - $58.89 $512,400 - $588,900	10,000 Added 80.65%	22,400 $1.19 Million
Q2 2022 Aug 15, 2022	SELL	$51.49 - $81.64 $51,490 - $81,640	-1,000 Reduced 7.46%	12,400 $723,000
Q1 2022 May 16, 2022	BUY	$60.03 - $76.49 $264,132 - $336,556	4,400 Added 48.89%	13,400 $1.02 Million
Q4 2021 Feb 14, 2022	SELL	$47.97 - $62.21 $513,279 - $665,647	-10,700 Reduced 54.31%	9,000 $542,000
Q3 2021 Nov 15, 2021	BUY	$54.64 - $61.3 $344,232 - $386,190	6,300 Added 47.01%	19,700 $1.1 Million
Q2 2021 Aug 11, 2021	SELL	$59.18 - $69.99 $864,028 - $1.02 Million	-14,600 Reduced 52.14%	13,400 $813,000
Q1 2021 May 17, 2021	SELL	$59.31 - $78.82 $510,066 - $677,851	-8,600 Reduced 23.5%	28,000 $1.96 Million
Q4 2020 Feb 16, 2021	BUY	$50.47 - $66.26 $469,371 - $616,218	9,300 Added 34.07%	36,600 $2.19 Million
Q3 2020 Nov 16, 2020	SELL	$51.97 - $63.0 $2.25 Million - $2.73 Million	-43,300 Reduced 61.33%	27,300 $1.64 Million
Q2 2020 Aug 14, 2020	BUY	$30.8 - $52.47 $344,960 - $587,664	11,200 Added 18.86%	70,600 $3.7 Million
Q1 2020 May 15, 2020	SELL	$28.4 - $50.7 $295,360 - $527,280	-10,400 Reduced 14.9%	59,400 $1.99 Million
Q4 2019 Feb 14, 2020	BUY	$36.31 - $46.83 $824,237 - $1.06 Million	22,700 Added 48.2%	69,800 $3.16 Million
Q3 2019 Nov 14, 2019	SELL	$35.66 - $44.99 $1.75 Million - $2.21 Million	-49,200 Reduced 51.09%	47,100 $1.79 Million
Q2 2019 Aug 14, 2019	SELL	$36.57 - $47.97 $2.5 Million - $3.28 Million	-68,300 Reduced 41.49%	96,300 $4.19 Million
Q1 2019 May 15, 2019	SELL	$36.47 - $42.17 $1.23 Million - $1.42 Million	-33,600 Reduced 16.95%	164,600 $6.27 Million
Q4 2018 Feb 14, 2019	BUY	$41.31 - $52.16 $2.38 Million - $3.01 Million	57,700 Added 41.07%	198,200 $8.53 Million
Q3 2018 Nov 14, 2018	BUY	$32.85 - $52.0 $413,910 - $655,200	12,600 Added 9.85%	140,500 $6.91 Million
Q2 2018 Aug 14, 2018	BUY	$27.5 - $39.8 $258,500 - $374,120	9,400 Added 7.93%	127,900 $4.1 Million
Q1 2018 May 15, 2018	SELL	$29.98 - $46.35 $1.72 Million - $2.67 Million	-57,500 Reduced 32.67%	118,500 $3.69 Million
Q4 2017 Feb 14, 2018	BUY	$31.85 - $46.95 $3.55 Million - $5.24 Million	111,600 Added 173.29%	176,000 $8.03 Million
Q3 2017 Nov 14, 2017	BUY	$35.7 - $39.5 $2.3 Million - $2.54 Million	64,400	64,400 $2.42 Million

Others Institutions Holding PCRX

# of Institutions

263

Shares Held

50.4M

Call Options Held

429K

Put Options Held

391K

Black Rock Inc. New York, NY

8.01M
Shares

$156 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.3M
Shares

$103 Million
0.0% of portfolio
Pacer Advisors, Inc. Malvern, PA

4.96M
Shares

$96.6 Million
0.18% of portfolio
State Street Corp Boston, MA

2.01M
Shares

$39.2 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.98M
Shares

$38.5 Million
0.05% of portfolio

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account